Replies to post #19035 on DNAprint Genomics (DNAG)

[DRCAL]

I once kept a company with great technology going for 15 years so I know the difficulty of the task. That's probably why I am lenient on management and give them a break. Unless you have fought the battle, you really don't know how hard it is to establish a company with any cutting edge technology. Basically, the large drug companies don't want you because your technology might interfere with their testing plans and drug pipeline. Then, the small biotechs don't like you because you are competing for money against them in the marketplace.
Actually, I think that this company will probably be saved by the adverse publicity that the major drug companies are receiving. However, DNAP must successfully meet the need for DNA pre-testing of sample populations used in clinical trials. In this way the drug companies will be able to know what types of people respond to drugs or don't respond and why they respond or don't respond on the basis of genetic differences.

[bigdrive99]

frogdreaming - Speaking of straigtforward honesty, has anyone ever gotten an answer as to Frudakis' association with SCII?
I think I remember someone quoting him at the shareholder's meeting that it has nothing to do with DNAP.
Any speculation?